Cantourage Group SE Company Description

Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally.

The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products.

It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners.

Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

Cantourage Group SE

Country	Germany
Founded	2019
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	11
CEO	Philip Schetter

Contact Details

Address: Feurigstr. 54 Berlin, 10827 Germany
Phone	49 30 4701 350 51
Website	cantourage.com

Stock Details

Ticker Symbol	HIGH
Exchange	Deutsche Börse Xetra
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2834

Key Executives

Name	Position
Philip Schetter	Chief Executive Officer and Chairman of Management Board
Monique Jaqqam	Chief Financial Officer and Member of Exceutive Board
Bernhard Retzer	Vice President Sourcing and Sales and Member of Executive Board
Constanze Pelzer	Vice President Quality and Regulatory Affairs and Member of Executive Board
Manuel Taverne	Head of Investor Relations